Woodline Partners LP

Holdings History for ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share (AVBP)

Symbol: AVBP on Nasdaq
Investment type: Equity / Common Stock, $0.0001 Par Value per Share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	-0.01%	$2,965,406	147,386	-149,530	-50%	$20.12	Q4 2025
30 Sep 2025	0.03%	+0.01%	$5,478,100	296,916	+150,000	+102%	$18.45	Q3 2025
30 Jun 2025	0.02%	+0%	$3,198,361	146,916	+543	+0.37%	$21.77	Q2 2025
31 Mar 2025	0.02%	+0%	$2,706,437	146,373	+576		$18.49	Q1 2025
31 Dec 2024	0.03%	+0%	$3,884,032	145,797	+24,853	+21%	$26.64	Q4 2024
30 Sep 2024	0.02%	+0%	$2,842,184	120,944	+20,944	+21%	$23.50	Q3 2024
30 Jun 2024	0.02%	0%	$1,855,000	100,000	0		$18.55	Q2 2024
31 Mar 2024	0.02%	+0.02%	$1,786,000	100,000	+100,000	NEW	$17.86	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.